LYPLAL1 and small cell lung carcinoma: These results demonstrate that LYPLAL1-DT derived from HUVEC exosomes significantly promotes the proliferation, migration, and invasion of SCLC cells, suggesting that EC could reversely contribute to SCLC tumor formation through exosomal LYPLAL1-DT.